ClinicalTrials.govpublic full text
CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy
autoimmune hemolytic anemia, cd19 car-t cell infusion, thiscart19a, relapsed/refractory after receiving three or more lines of therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827811
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.